Eli Lilly: Searching for New Tuberculosis Drugs

Nisa PatelArticle

Most TB drugs currently approved for treatment are 50+ years old and are required to be taken over a 6-month period to be effective. Compliance with such a long treatment regimen is a challenge, limiting drugs’ effectiveness and contributing to the rise in MDR-TB. As part of its MDR-TB Partnership, Eli Lilly and Company formed innovative partnerships with the Infectious … Read More

Nisa PatelEli Lilly: Searching for New Tuberculosis Drugs

Meet the PSD: Erika Satterwhite & René Cazetien

Nisa PatelArticle

Erika Satterwhite Manager, Global Policy, Mylan René Cazetien Associate Vice President of Operations, Access to Medicines, Sanofi How did Mylan become involved with the Global Fund? Mylan’s decision to join the PSD Advisory Group is rooted in the company’s desire to provide the often-missing generic manufacturer’s perspective in shaping good public policy around the Global Fund’s efforts to combat HIV/AIDS, TB, … Read More

Nisa PatelMeet the PSD: Erika Satterwhite & René Cazetien

Must Read: Articles from World Malaria Day

Nisa PatelArticle

The global malaria community observed World Malaria Day on April 25th. This year’s theme, “Invest in the Future: Defeat Malaria,” focused attention on the impact of the disease and its implications for the post-2015 development agenda. The world has moved closer to achieving malaria elimination: since 2000, malaria-related deaths have reduced by 42% globally and 49% in Africa, resulting in … Read More

Nisa PatelMust Read: Articles from World Malaria Day

PSC Perspectives: The Burgeoning Problem of Insecticide Resistance

Nisa PatelArticle

By Egon Weinmueller, Head of Business Management Global Public Health, BASF Vector control measures have helped reduce malaria-related sickness and death worldwide.  However, mosquito resistance to insecticides presents a growing challenge. Two thirds of countries with ongoing malaria transmission now report insecticide resistance and without proper intervention[1] the problem could lead to a dramatic and devastating resurgence. Growing metabolic resistance … Read More

Nisa PatelPSC Perspectives: The Burgeoning Problem of Insecticide Resistance

Frequently Asked Questions: GBCHealth Changes and Future Direction

hcoulsonArticle

Q.   We’re budgeting for 2014 now.  I know we won’t be invoiced for membership dues. Should we earmark funds for GBCHealth? A.   We welcome continued engagement and support from members. If you are interested in discussing opportunities with GBCHealth, please contact your relationship manager or Executive Director Michael Schreiber at mschreiber@gbchealth.org. We will continue to be registered in the United States … Read More

hcoulsonFrequently Asked Questions: GBCHealth Changes and Future Direction

Letter to Our Network: GBCHealth Changes and Future Direction

hcoulsonArticle

GBCHealth is announcing to our broad network today changes in how we engage with member companies and organizations going into 2014.  The purpose of these changes is to sharpen our focus on how the private sector can best support achievement of high-priority global health goals in view of a significantly changed private-public landscape since our founding in 2001. For 2014, … Read More

hcoulsonLetter to Our Network: GBCHealth Changes and Future Direction

Linkages between Malaria and Agriculture

hcoulsonArticle

Introduction The connections between agriculture and health are major and go both ways. Good health enhances agricultural productivity, and the intake of nutritious plant-based foods supports good health. Governments and corporations recognize the relevance of agriculture to maintain food security and generate economic benefits. Expansion of agricultural practices such as irrigation farming, use of chemical fertilizer and biotechnology farming, have … Read More

hcoulsonLinkages between Malaria and Agriculture